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In Europe, enterovirus A71 (EV-A71) has primarily been 
associated with sporadic cases of neurological dis-
ease. The recent emergence of new genotypes and 
larger outbreaks with severely ill patients demon-
strates a potential for the spread of new, highly patho-
genic EV-A71 strains. Detection and characterisation 
of these new emerging EV variants is challenging as 
standard EV assays may not be adequate, necessitat-
ing the use of whole genome analysis.
Enterovirus A71 (EV-A71) has been detected in Denmark 
in relatively low numbers since 2001. Of the different 
genotypes of EV-A71, only B5, C1, C2, and C4 have 
been identified [1,2]. All genotypes have been either 
associated with neurological symptoms, or milder 
hand, foot, and mouth disease (HFMD) in Denmark. 
EV-A71 subtype C4a, commonly circulating in Asia, has 
been identified as the cause of extensive outbreaks of 
HFMD with neurological complications and fatalities 
[3,4]. During a pilot project validating next generation 
sequencing (NGS) technology for full genome typing of 
EVs at the National World Health Organization (WHO) 
Reference Laboratory for Poliovirus at Statens Serum 
Institut (SSI), a novel EV-A71 variant was identified. This 
variant was shown to be genetically closely related to 
a recently published novel EV-A71 genotype C1 recom-
binant variant identified in Germany [5,6]. Re-analysis 
of sequence data and full genome re-sequencing of 
selected samples from the Danish EV surveillance 
database revealed additional viruses phylogenetically 
closely related to this new variant.
Laboratory analyses
Samples included in the analysis were collected 
through the Danish EV surveillance system [7]. They 
were genotyped using VP2 and/or VP1 PCR assays 
[8,9] and sequenced as described previously [2]. All 
20 EV-A71 cases from 2016, as well as additional 12 
historical cases previously subtyped as C1 were ana-
lysed. NGS was carried out directly on clinical sample 
material, as described previously [10], for a subset of 
samples (n = 10) and one sample was characterised 
from cultured material obtained as part of another 
study. The Illumina MiSeq platform was used to gen-
erate the sequencing data that were analysed using 
the CLC genomics workbench. Consensus sequences 
were exported as fasta files, and aligned with all avail-
able full-length EV-A71 genomes downloaded from the 
National Center for Biotechnology Information (NCBI) 
GenBank using SSE v1.3[11]. Phylogenetic analysis was 
carried out using MEGA 6 [12], maximum likelihood 
with a general time reversible model, gamma distribu-
tion and invariable sites, and 1,000 bootstrap replica-
tions. Bootscanning analysis was also carried out using 
SimPlot v3.5.1 [13]. Sequences have been submitted to 
GenBank, accession numbers pending.
Enterovirus A71 genotype C cases 
2001–2016
The most common sample material available for the 32 
EV-71 RNA-positive patients was stool (n = 22) followed 
by vesicular fluid (n = 6). Other sample materials were 
urine, cerebrospinal fluid (CSF), respiratory secretion 
and biopsy. (Table 1).
Patient ages ranged from 7 days to 36 years with a 
median of 3 months and inter-quartile ranges of 2 and 
12 months, respectively, and 11 of 32 patients were 
females. Clinical information was available for 23 of 
32 cases, collected as part of the enhanced EV sur-
veillance system in place [7]. Six cases had HFMD, 11 
had gastrointestinal symptoms, 14 had fever, five had 
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Figure 1
Phylogenetic analysis of enterovirus A71 genotype C cases, Denmark, 2001–2016
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German new variant strains are identified with a capital N as a prefix, Danish strains are identified by the case ID as described in Table 1 
prefixed by DK. Genotypes C1 and C6 are marked with brackets. Reference sequences for other genotypes are prefixed by the genotype, 
followed by the GenBank accession number.
Phylogenetic analysis was carried out using MEGA 6 [12], maximum likelihood with a general time reversible model, gamma distribution and 
invariable sites and 1,000 bootstrap replications. The bootstrap support is indicated at nodes, showing only values of > 70%. The bar denotes 
0.05 nt substitutions per site.
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central nervous system involvement (Guillain–Barré 
syndrome, meningitis, encephalitis), and there was 
one death. The death and one of the sepsis cases were 
associated with a bacterial co-infection (Clostridium 
difficile and group B Streptococcus, respectively). 
Hospital admission data was available for 13 cases, 
and the hospitalisation ranged from less than one day 
to 10 days (average 3.6 days, SD 2.8).
Phylogenetic analysis
Phylogenetic analysis of partial VP2/VP4 and /or VP1 
sequence data showed that 17 samples could be char-
acterised as belonging to EV-A71 genotype C1 and 13 
samples were closer to a new variant recently identi-
fied in our laboratory. Moreover, one EV-A71 genotype 
C2 and one C4 were identified (Figure 1). NGS data was 
obtained for a total of 11 strains, nine were found to 
belong to the new genotype, and two were C1 (Figure 
2).
In the VP1 and near-full genome phylogenetic analyses, 
the new variant forms a clade separately from other C1 
viruses. The new recombinant strain was identified in 
a sample dating back to 2007. In the WGS three clades 
were seen: (i) one containing Danish strains from 2007 
and 2016 as well as strains from Germany, (ii) one with 
single Danish strains from 2014 and 2016, and (iii) one 
with two Danish strains from 2016. There was no dif-
ference between the genotypes regarding the clinical 
symptoms of the cases (Table 1). In the VP2 analysis it 
was not possible to clearly distinguish between C1 and 
the new variant.
Bootscanning analysis showed that Danish new vari-
ants were nearly identical to the German new variants 
over the majority of the genome. However, there was no 
similarity in the 3Dpol region, where both the German 
and the Danish strains differed from all published sub-
types (Figure 3). The German strains appear to have a 
Figure 2
Phylogenetic analysis of near-complete genome sequences, enterovirus A71 genotype C cases, Denmark, 2001–2016
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German new variant strains are identified with a capital N as a prefix, Danish strains are identified by the case ID as described in Table 1 
prefixed by DK. Genotypes C1 and C6 are marked with brackets. Reference sequences for other genotypes are prefixed by the genotype, 
followed by the GenBank accession number.
Phylogenetic analysis was carried out using MEGA 6 [12], maximum likelihood with a general time reversible model, gamma distribution and 
invariable sites, and 1,000 bootstrap replications. The bootstrap support is indicated at nodes. The bar denotes 0.05 nt substitutions per site.
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mosaic genome, more closely related to different geno-
types in different parts of the genome. When analysed 
without comparison to the German strain, the Danish 
variant also showed a similar mosaic genome (Figure 
3). Both strains appear to be closest to C1 in the VP1 
region of the genome.
Discussion and conclusions
This study documents the circulation of new emerging 
EV-A71 genotype C variants associated with neurologic 
symptoms, as well as HFMD, in the Danish popula-
tion. Novel EV-A71 variants were detected with WGS, 
and could be traced back to the first detection in the 
Danish population in 2007. Phylogenetically, a higher 
level of genetic variation was seen among the Danish 
strains as compared with the previously reported 
German EV-A71 C1 variant strains [5,6] suggesting that 
these novel variants have arisen from genetic reassort-
ment of EV-A71 viruses over a prolonged period of time.
Three EV-A71 C variant clades were identified in 
Denmark one of which contains Danish EV-A71 C 
strains from 2007 and 2016 as well as the German 2015 
strains. The phylogenetic analyses in this study show 
that the new variant EV-A71 sub-genotype C viruses 
form a clade separate from the C1 viruses, and the 
Figure 3
Bootscanning and SimPlot analysis of novel enterovirus A71 genotype C cases DK-14–03 (Denmark 2014) and KU641506 
(Germany 2015)
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Table 
Clinical description of enterovirus A71 genotype C cases, Denmark, 2001–2016 (n = 32)
Year of 
detection–
case ID
Age Sample material Sequence typea EV-A71 genotype Symptoms
Hospital 
admission
01–01 1–2 years Unknown VP2 C1 Guillain–Barré syndrome Unknown
07–01 5–10 years Vesicular fluid VP2,WGS C6 Vesicles Unknown
07–02 < 6 months Stool VP1,VP2,WGS C1 Unknown Unknown
07–03 < 6 months Stool VP1,VP2,WGS C6 Unknown Unknown
07–04 1–2 years Stool VP1,VP2,WGS C1 Diarrhoea for 3 weeks after travelling Unknown
07–05 < 6 months Stool and urine VP1,VP2 C1 Meningitis, fever, abdominal pain Unknown
10–01 35–40 years Vesicular fluid VP1,VP2 C1 HFMD– rash, vesicles < 1 day
10–02 0–2 months Stool VP2 C1 Sepsis – fever > 38.5, diarrhoea, vomiting blood 5 days
10–03 0–2 months Stool and CSF VP1,VP2 C1 Meningitis Unknown
14–01 25–30 years Vesicular fluid VP1,VP2 C1 HFMD – rash, vesicles No
14–02 1–2 years Respiratory secretion VP2 C1 Respiratory symptoms Unknown
14–03 < 6 months Unknown VP1,VP2,WGS C6 Fever > 38.5 °C, diarrhoea, vomiting 1 day
16–01 < 6 months Small intestine biopsy VP1 C4
Sudden death, also Clostridium 
difficile infection Unknown
16–02 < 6 months Stool VP1,VP2,WGS C6 Fever > 38.5 °C, diarrhoea, rash 1 day
16–03 1–2 years Vesicular fluid VP2,WGS C6 HFMD – rash, vesicles no
16–04 < 6 months Stool VP1,VP2,WGS C6 Fever > 38.5 °C, diarrhoea, rash < 1 day
16–05 6–11 months Stool VP1,VP2,WGS C6 HFMD – fever > 38.5 °C, rash, vesicles, vomiting 6 days
16–06 < 6 months Stool VP1,VP2,WGS C new/C6 b HFMD – fever > 38.5 °C, rash, vesicles, respiratory symptoms 4 days
16–07 < 6 months Stool VP2 C1
Encephalitis – fever > 38.5 °C, 
abnormal sensitivity to stimuli, 
diarrhoea, rash, respiratory 
symptoms, sepsis-like symptoms
5 days
16–08 4–5 years Stool VP2,WGS C new/C6 b
Meningitis –neck stiffness, 
affected consciousness, fever, 
rash, vomiting
5 days
16–09 < 6 months Stool VP1,VP2 C1 Unknown Unknown
16–10 1–2 years Stool VP1 C1 Unknown Unknown
16–11 1–2 years Stool VP2 C1/C6 c Fever, rash, vesicles, diarrhoea Unknown
16–12 < 6 months Stool VP1 C1 Fever > 38.5 °C, rash 4 days
16–13 < 6 months Stool VP1,VP2 C1 Unknown Unknown
16–14 < 6 months Stool VP2 C1/C6 c Fever > 38.5 °C, group B Streptococcus sepsis 10 days
16–15 < 6 months Stool VP2 C1 Fever 7 days
16–16 < 6 months Stool VP1 C6 Fever > 38.5 °C, vomiting, sepsis 4 days
16–17 < 6 months Stool VP2 C1/C6 c Unknown Unknown
16–18 1–2 years Vesicular fluid VP2 C1 Unknown Unknown
16–19 25–30 years Vesicular fluid VP2 C1 Unknown Unknown
16–20 1–2 years Stool VP2 C2 Unknown Unknown
HFMD: hand, foot, and mouth disease.
a VP1: sequence was obtained from VP1 PCR; VP2: sequence was obtained from VP2 PCR; WGS: sequence was obtained from whole genome 
sequencing.
b Grouping with C6 in near-complete genome analysis, but not with C6 or C1 in VP1 analysis. c Grouping with C6 when analysing the VP1 
region, but no complete genome sequence available and therefore not possible to confidently assign as C6.
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authors propose that these new variants are seen as a 
new genotype, C6, rather than a lineage of C1.
Both German and Danish new variants appear to be 
recombinant forms, with 3Dpol regions of separate 
origins. This was previously described for the German 
strains [6]. In fact, both the German and Danish strains 
appear to be mosaic, a result of several recombina-
tion events throughout the genome. The co-circulation 
of multiple genotypes of EV-A71 in one country during 
a single season/year, as demonstrated in this study, 
provides the environment for the appearance of future 
novel recombinant variants.
EV-A71 genotype C4 subtypes associated with more 
severe clinical outcomes than other EV-A71 genotypes 
and subtypes have previously been described [3,4]. 
The new C variant was described as emerging in 2015 
in Germany and associated with rhomboencephalitis/
brainstem encephalitis and severe neurological and 
cardiopulmonary complications [5,6,14]. However, the 
collection of samples for the EV surveillance system, 
as in the case of Denmark and Germany, may introduce 
a bias in this regard. The new EV-A71 genotype C vari-
ant identified in Denmark in 2016, was associated with 
both neurological symptoms and HFMD, illustrating the 
ability of EVs to cause a wide range of symptoms with 
rare cases of severe complications.
New emerging EVs have already demonstrated their 
potential to cause devastating epidemics such as the 
major EV-A71 epidemics in Asia and South Pacific 
Region. There is therefore a need to detect and moni-
tor these viruses closely. In addition to detection and 
reporting of an emerging new EV-A71 recombinant 
virus, a proposed genotype C6, this study demon-
strates important challenges in detection as well as 
characterisation of emerging EV infections. Current 
state-of-the-art EV PCR-based methods continuously 
need to undergo evaluation to ensure that primers for 
diagnostics, as well as typing, maintain the ability to 
detect and fully classify new EV variants beyond the 
(sero)type level. PCR-based typing relies on the ampli-
fication of short genome fragments, and as a conse-
quence may not only result in missed detection of new 
genotypes, but also in misclassification due to a lack of 
appropriate reference sequences. Furthermore, timely 
and public sharing of whole EV genome sequence data 
are essential for detection of new variants.
The possible severity of EV-A71 infections together 
with the continuing evolution and appearance of new 
EV-A71 genotypes, as well as other emerging EV caus-
ing neurological disease, underscores the importance 
and relevance to prioritise strengthening of EV surveil-
lance globally.
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